Sosei Group Corporation, a biopharmaceutical company, discovers, develops, and commercializes biopharmaceutical products worldwide. Its marketed products include Seebri/NVA237, an inhaled long-acting muscarinic antagonist indicated as a maintenance bronchodilator treatment for chronic obstructive pulmonary disease (COPD); Ultibro/QVA149, an inhalation capsule for the bronchodilator treatment of COPD; and NorLevo, an oral emergency contraceptive. The company's product pipeline consists of SO-1105, an antifungal agent, which is in Phase III clinical trial for the treatment of oropharyngeal candidiasis in immunocompromised patients; and APP13002 and APP13007, which are in pre-clinical stage for infectious eye diseases, such as cornea and conjunctivitis, and inflammation. It also develops JIT-2001 for cardiovascular disease and JIT-1007 for orphan diseases that are in pre-clinical stage; and discovers and develops pharmaceutical products targeting G protein-coupled receptors. In addition, the company is developing biopharmaceuticals for the treatment of Alzheimer's disease, schizophrenia, cancer, migraine, addiction, metabolic diseases, and other indications. The company has a strategic collaboration with PeptiDream Inc. Sosei Group Corporation was founded in 1990 and is headquartered in Tokyo, Japan.
Industry, Sector and Symbol
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone81 3 5210 3290
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Sosei Group (OTCMKTS:SOLTF) Frequently Asked Questions
What is Sosei Group's stock symbol?
Sosei Group trades on the OTCMKTS under the ticker symbol "SOLTF."
Has Sosei Group been receiving favorable news coverage?
Media coverage about SOLTF stock has trended somewhat negative recently, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Sosei Group earned a media sentiment score of -1.4 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for Sosei Group.
Who are some of Sosei Group's key competitors?
Some companies that are related to Sosei Group include Abattis Bioceuticals (ATTBF), ABcann Global (ABCN), ABZENA/PAR VTG FPD 0.002 (ABZA), Almirall (LBTSF), Apotheca Biosciences (CBDC), Arno Therapeutics (ARNI), Axim Biotechnologies (AXIM), Biocure Technology (CURE), Canada House Wellness Group (CHV), Cannabics Pharmaceuticals (CNBX), CannaRoyalty (ORHOF), Cardiome Pharma (COM), China Longyi Group Int'l (CGYG), Creative Medical Technology (CELZ) and Cyclacel Pharmaceuticals Inc 6% Conv. Pref. Shrs (CYCCP).
What other stocks do shareholders of Sosei Group own?
Who are Sosei Group's key executives?
Sosei Group's management team includes the folowing people:
- Mr. Shinichi Tamura, Founder, Exec. Chairman, Representative Exec. Officer, Pres & CEO (Age 70)
- Mr. Chris Cargill, Exec. VP & CFO
- Kazuhiko Yoshizumi, Exec. VP of Corp. Admin. & Group Chief Compliance Officer
- Shinichiro Nishishita, VP of Corp. Communication Department
- Dr. Malcolm Weir Ph.D., Exec. VP and Chief R&D Officer (Age 61)
How do I buy shares of Sosei Group?
Shares of SOLTF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Sosei Group's stock price today?
One share of SOLTF stock can currently be purchased for approximately $23.58.
What is Sosei Group's official website?
How can I contact Sosei Group?
The company can be reached via phone at 81 3 5210 3290.
MarketBeat Community Rating for Sosei Group (OTCMKTS SOLTF)
MarketBeat's community ratings are surveys of what our community members think about Sosei Group and other stocks. Vote "Outperform" if you believe SOLTF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SOLTF will underperform the S&P 500 over the long term. You may vote once every thirty days.
